Related Experiment Video
Updated: Jul 12, 2026
08:41
Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters
Published on: June 23, 2023
Resolving human α versus β cell fate allocation for the generation of stem cell-derived islets
Melis Akgün Canan1,2,3,4, Corinna Cozzitorto1,5, Michael Sterr1,2,5
1Institute of Diabetes and Regeneration Research, Helmholtz Center Munich, Neuherberg, Germany.
Nature Communications
|July 9, 2026
Summary
Human stem cell research reveals a unique mechanism for allocating alpha and beta cell fates, crucial for diabetes research and cell therapy. This study advances understanding of pancreatic islet development.
Area of Science:
- Developmental Biology
- Stem Cell Biology
- Endocrinology
Background:
- Stem cell-derived alpha and beta cells engineer in vitro biomimetics of the islet of Langerhans, vital for glycemia control.
- A knowledge gap exists in the precise mechanisms governing human stem cell-derived alpha and beta cell specification.
- Previous mouse studies suggested a cross-inhibitory model between Aristaless Related homeobox (Arx) and Paired box 4 (Pax4) transcription factors for alpha/beta fate allocation.
Purpose of the Study:
- To investigate the mechanism of human stem cell-derived alpha and beta cell fate allocation.
- To test the conserved role of Arx and Pax4 cross-inhibition in human pancreatic endocrine progenitor specification.
- To identify novel regulatory pathways and potential therapeutic targets for enhancing islet cell generation.
Main Methods:
- Generation of a novel human induced pluripotent stem cell reporter line (ARXCFP/CFP; PAX4mCherry/mCherry) for lineage tracing.
- Application of single-cell multiomic analysis, including lineage tracing, proteomics, and gene regulatory network analysis.
- Utilized potency assays and pharmacological perturbations to modulate cell fate decisions.
Main Results:
- Revealed a human-specific regulation of alpha/beta cell fate allocation, diverging from the postulated mouse model.
- Gene regulatory network analysis identified key factors and pathways involved in human endocrinogenesis.
- Pharmacological interventions, guided by the study's findings, enhanced both endocrine induction and directed alpha/beta cell fate.
Conclusions:
- The study elucidates a distinct mechanism for human alpha/beta cell fate determination, distinct from murine models.
- Understanding these mechanisms is key to engineering functional human islets in vitro for cell-replacement therapy.
- Findings have significant implications for diabetes research, disease modeling, and drug screening platforms.
Related Concept Videos
01:23Tissue Renewal without Stem Cells
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
However, failure of such a system...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.